ZAI LAB LTD-ADR (ZLAB)
US98887Q1040 - ADR
Zai Lab Announces Participation in May and June Investor Conferences
Zai Lab Announces Approval of AUGTYRO™ (repotrectinib) for Patients with ROS1-positive NSCLC by China’s NMPA
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:ZLAB),(NASDAQ:NTBL),(NASDAQ:CRDF),(NYSE:JNJ) EQNX::TICKER_END
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036
/PRNewswire/ -- The incidence of pancreatic cancer is increasing globally, which is driving the growth of the market. As of 2023, the American Cancer Society...
Gapping stocks in Thursday's session
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Thursday's pre-market session: top gainers and losers
Curious about the stocks that are showing activity before the opening bell on Thursday?
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday!
ZLAB Stock Earnings: Zai Lab Beats EPS, Beats Revenue for Q1 2024
ZLAB stock results show that Zai Lab beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
ZLAB Stock Earnings: Zai Lab Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Zai Lab (NASDAQ:ZLAB) just reported results for the first quarter of 2024.Zai L...
Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates
Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024
Zai Lab Statement on Executive Management Team’s Agreement on Share Activities
Shhh! 7 Small-Cap Stocks That Can Double by 2025
Small-cap stocks have been hot and these shares discussed here are likely to heat up and double over the next year.
Zai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid Tumors
Zai Lab Announces Participation in March Investor Conference
Zai Lab Announces Full-Year 2023 Financial Results and Recent Corporate Updates
Qiming Venture Partners Becomes a UN PRI Signatory
/PRNewswire/ -- China's leading venture capital firm Qiming Venture Partners announced its recent signing of the United Nations-supported Principles for...
Cantor sees weakness in Zai Lab stock as buying opportunity (NASDAQ:ZLAB)
Cantor Fitzgerald said it sees current weakness in Zai Lab's (ZLAB) stock as a buying opportunity ahead of a “busy catalyst-rich year.” The investment bank said
Zai Lab to Announce Full-Year 2023 Financial Results and Recent Corporate Updates on February 27, 2024
Zai Lab is Now Oversold (ZLAB)
NovoCure stock gains on J.P. Morgan event (NASDAQ:NVCR)
Novocure's (NVCR) stock adds 12% as the company confirms its participation at the J.P. Morgan Healthcare Conference next month. Read more here.
